Stratasys Releases First Quarter 2022 Financial Results
Stratasys Ltd. (Nasdaq: SSYS) reported first-quarter 2022 revenue of $163.4 million, marking a 22% increase over 2021, the highest first-quarter revenue in six years. Despite a GAAP net loss of $20.9 million or $0.32 per diluted share, non-GAAP net income was $1.2 million or $0.02 per share. The company holds $475.6 million in cash with no debt. For 2022, Stratasys revised its revenue guidance to a range of $685-$695 million, anticipating low to mid-teens growth in Q2. GAAP net loss for the year is expected between $74-$67 million.
- 22% revenue growth year-over-year.
- Highest first-quarter revenue in six years.
- Strong performance from systems, up 36.7%.
- GAAP net loss of $20.9 million.
- Operating expenses projected to increase by $20-$25 million.
-
First quarter revenue of
,$163.4 million 22% growth over first quarter 2021, highest first quarter revenue in six years -
First quarter GAAP net loss of
, or$20.9 million per diluted share, and non-GAAP net income of$0.32 , or$1.2 million per diluted share$0.02 -
cash and equivalents and no debt as of$475.6 million March 31, 2022
Summary - First Quarter 2022 Financial Results Compared to First Quarter 2021:
-
Revenue of
, compared to$163.4 million .$134.2 million -
GAAP gross margin of
42.6% , compared to41.4% . -
Non-GAAP gross margin of
47.3% , compared to46.7% . -
GAAP operating loss of
, compared to a GAAP operating loss of$19.6 million .$18.4 million -
Non-GAAP operating income of
, compared to non-GAAP operating loss of$2.0 million .$2.6 million -
GAAP net loss of
, or$20.9 million per diluted share, compared to net loss of$0.32 , or$18.9 million per diluted share.$0.32 -
Non-GAAP net income of
, or$1.2 million per diluted share, compared to non-GAAP net loss of$0.02 , or$3.8 million per diluted share.$0.06 -
Adjusted EBITDA of
, compared to$8.1 million .$3.5 million -
of cash used by, compared to$16.1 million of cash generated from, operating activities, reflecting more inventory purchasing and increase in accounts receivable.$22.8 million
Dr.
Financial Outlook:
Based on current market conditions and assuming that the impact of the COVID-19 pandemic or global supply chain costs do not impede economic activity further, the Company is tightening its revenue guidance range for 2022:
-
Full year revenue of
to$685 million .$695 million - Sequential quarterly revenue growth.
- Second quarter revenue growth expected to reach low to mid-teens as a percentage over second quarter of 2021.
- Based on current logistics and materials costs, full-year gross margins of flat to slightly higher than in 2021, with improved year-over-year growth in the second half of 2022.
-
Full year-operating expenses that are
to$20 million higher than 2021, primarily due to ongoing investments in new products to drive higher revenue.$25 million -
Full year non-GAAP operating margins slightly above
2% . -
GAAP net loss of
to$74 million , or ($67 million ) to ($1.11 ) per diluted share.$1.00 -
Non-GAAP net income of
to$10 million , or$13 million to$0.14 per diluted share.$0.19 -
Adjusted EBITDA of
to$38 million .$41 million -
Capital expenditures of
to$20 million .$25 million
Non-GAAP earnings guidance excludes
Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.
The Company plans to webcast its conference call to discuss its first quarter 2022 financial results on
The investor conference call will be available via live webcast on the
https://services.choruscall.com/mediaframe/webcast.html?webcastid=QiDdBAQK
To participate by telephone, the
To learn more about
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.
Consolidated Balance Sheets | ||||||||
(Unaudited) | ||||||||
(in thousands, except share data) | ||||||||
|
|
|||||||
2022 |
2021 |
|||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ |
293,649 |
|
$ |
243,179 |
|
||
Short-term deposits |
|
182,000 |
|
|
259,000 |
|
||
Accounts receivable, net of allowance for credit losses of |
|
136,444 |
|
|
129,382 |
|
||
Inventories |
|
143,116 |
|
|
129,147 |
|
||
Prepaid expenses |
|
8,477 |
|
|
6,871 |
|
||
Other current assets |
|
24,185 |
|
|
33,123 |
|
||
Total current assets |
|
787,871 |
|
|
800,702 |
|
||
Non-current assets | ||||||||
Property, plant and equipment, net |
|
200,627 |
|
|
203,295 |
|
||
|
65,089 |
|
|
65,144 |
|
|||
Other intangible assets, net |
|
143,317 |
|
|
152,244 |
|
||
Operating lease right-of-use assets |
|
14,162 |
|
|
14,651 |
|
||
Long-term investments |
|
28,667 |
|
|
28,667 |
|
||
Other non-current assets |
|
16,651 |
|
|
12,519 |
|
||
Total non-current assets |
|
468,513 |
|
|
476,520 |
|
||
Total assets | $ |
1,256,384 |
|
$ |
1,277,222 |
|
||
LIABILITIES AND EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable | $ |
59,010 |
|
$ |
51,976 |
|
||
Accrued expenses and other current liabilities |
|
44,198 |
|
|
55,358 |
|
||
Accrued compensation and related benefits |
|
38,341 |
|
|
44,684 |
|
||
Deferred revenues - short term |
|
52,337 |
|
|
51,174 |
|
||
Operating lease liabilities - short term |
|
7,158 |
|
|
7,276 |
|
||
Total current liabilities |
|
201,044 |
|
|
210,468 |
|
||
Non-current liabilities | ||||||||
Deferred revenues - long term |
|
22,026 |
|
|
21,133 |
|
||
Deferred income taxes - long term |
|
6,258 |
|
|
7,341 |
|
||
Operating lease liabilities - long term |
|
7,220 |
|
|
7,693 |
|
||
Contingent consideration |
|
53,648 |
|
|
53,478 |
|
||
Other non-current liabilities |
|
23,487 |
|
|
21,095 |
|
||
Total non-current liabilities |
|
112,639 |
|
|
110,740 |
|
||
Total liabilities |
|
313,683 |
|
|
321,208 |
|
||
Equity | ||||||||
Ordinary shares, |
||||||||
shares; 66,408 thousands shares and 65,667 thousands shares issued | ||||||||
and outstanding at |
|
185 |
|
|
182 |
|
||
Additional paid-in capital |
|
3,021,166 |
|
|
3,012,481 |
|
||
Accumulated other comprehensive loss |
|
(9,824 |
) |
|
(8,771 |
) |
||
Accumulated deficit |
|
(2,068,826 |
) |
|
(2,047,878 |
) |
||
|
942,701 |
|
|
956,014 |
|
|||
Total liabilities and equity | $ |
1,256,384 |
|
$ |
1,277,222 |
|
Consolidated Statements of Operations | ||||||||
(in thousands, except per share data) | ||||||||
Three Months Ended |
||||||||
2022 |
|
2021 |
||||||
(unaudited) |
|
(unaudited) |
||||||
Net sales | ||||||||
Products | $ |
113,073 |
|
$ |
90,324 |
|
||
Services |
|
50,356 |
|
|
43,865 |
|
||
|
163,429 |
|
|
134,189 |
|
|||
Cost of sales | ||||||||
Products |
|
59,373 |
|
|
46,920 |
|
||
Services |
|
34,379 |
|
|
31,692 |
|
||
|
93,752 |
|
|
78,612 |
|
|||
Gross profit |
|
69,677 |
|
|
55,577 |
|
||
Operating expenses | ||||||||
Research and development, net |
|
23,998 |
|
|
20,601 |
|
||
Selling, general and administrative |
|
65,263 |
|
|
53,334 |
|
||
|
89,261 |
|
|
73,935 |
|
|||
Operating loss |
|
(19,584 |
) |
|
(18,358 |
) |
||
Financial expense, net |
|
(1,362 |
) |
|
(377 |
) |
||
Loss before income taxes |
|
(20,946 |
) |
|
(18,735 |
) |
||
Income tax benefit |
|
73 |
|
|
942 |
|
||
Share in losses of associated companies |
|
(75 |
) |
|
(1,118 |
) |
||
Net loss | $ |
(20,948 |
) |
$ |
(18,911 |
) |
||
Net loss per share | ||||||||
Basic | $ |
(0.32 |
) |
$ |
(0.32 |
) |
||
Diluted | $ |
(0.32 |
) |
$ |
(0.32 |
) |
||
Weighted average ordinary shares outstanding | ||||||||
Basic |
|
65,721 |
|
|
58,616 |
|
||
Diluted |
|
65,721 |
|
|
58,616 |
|
Three Months Ended |
||||||||||||||||||||||||
2022 |
|
Non-GAAP |
|
2022 |
|
2021 |
|
Non-GAAP |
|
2021 |
||||||||||||||
GAAP |
|
Adjustments |
|
Non-GAAP |
|
GAAP |
|
Adjustments |
|
Non-GAAP |
||||||||||||||
|
||||||||||||||||||||||||
Gross profit (1) | $ |
69,677 |
|
$ |
7,689 |
|
$ |
77,366 |
$ |
55,577 |
|
$ |
7,069 |
|
$ |
62,646 |
|
|||||||
Operating income (loss) (1,2) |
|
(19,584 |
) |
|
21,607 |
|
|
2,023 |
|
(18,358 |
) |
|
15,785 |
|
$ |
(2,573 |
) |
|||||||
Net income (loss) attributable to |
|
(20,948 |
) |
|
22,158 |
|
|
1,210 |
|
(18,911 |
) |
|
15,111 |
|
$ |
(3,800 |
) |
|||||||
Net income (loss) per diluted share attributable to |
$ |
(0.32 |
) |
$ |
0.34 |
|
$ |
0.02 |
$ |
(0.32 |
) |
$ |
0.26 |
|
$ |
(0.06 |
) |
|||||||
(1) |
Acquired intangible assets amortization expense |
|
6,966 |
|
|
5,356 |
|
|||||||||||||||||
Non-cash stock-based compensation expense |
|
900 |
|
|
634 |
|
||||||||||||||||||
Restructuring and other related costs |
|
(177 |
) |
|
1,079 |
|
||||||||||||||||||
|
7,689 |
|
|
7,069 |
|
|||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
2,225 |
|
|
2,192 |
|
|||||||||||||||||
Non-cash stock-based compensation expense |
|
7,633 |
|
|
6,571 |
|
||||||||||||||||||
Restructuring and other related costs |
|
555 |
|
|
1,810 |
|
||||||||||||||||||
Revaluation of investments |
|
1,061 |
|
|
(3,670 |
) |
||||||||||||||||||
Contingent consideration |
|
207 |
|
|
191 |
|
||||||||||||||||||
Other expenses |
|
2,237 |
|
|
1,622 |
|
||||||||||||||||||
|
13,918 |
|
|
8,716 |
|
|||||||||||||||||||
|
21,607 |
|
|
15,785 |
|
|||||||||||||||||||
(3) |
Corresponding tax effect and other expenses |
|
551 |
|
|
(674 |
) |
|||||||||||||||||
$ |
22,158 |
|
$ |
15,111 |
|
|||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding- Diluted |
|
65,721 |
|
|
67,060 |
|
58,616 |
|
|
58,616 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220516005369/en/
CCO, VP Investor Relations
Yonah.Lloyd@stratasys.com
Source:
FAQ
What were Stratasys's revenue and net loss in Q1 2022?
How does Stratasys's Q1 2022 performance compare to Q1 2021?
What is Stratasys's revenue guidance for 2022?